APA (7th ed.) Citation

H, A., Z, C., U, Y., FP, F., FCE, V., JP, V., . . . JP, F. A. (2023). LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma. EMBO molecular medicine, 15(8), e18014. https://doi.org/10.15252/emmm.202318014

Chicago Style (17th ed.) Citation

H, Alborzinia, et al. "LRP8-mediated Selenocysteine Uptake Is a Targetable Vulnerability in MYCN-amplified Neuroblastoma." EMBO Molecular Medicine 15, no. 8 (2023): e18014. https://doi.org/10.15252/emmm.202318014.

MLA (9th ed.) Citation

H, Alborzinia, et al. "LRP8-mediated Selenocysteine Uptake Is a Targetable Vulnerability in MYCN-amplified Neuroblastoma." EMBO Molecular Medicine, vol. 15, no. 8, 2023, p. e18014, https://doi.org/10.15252/emmm.202318014.